Invus Global Management LLC 13D and 13G filings for Bicara Therapeutics Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-09-26 4:30 pm Purchase | 2024-09-16 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Invus Global Management LLC | 3,072,827 5.700% | 3,072,827 (New Position) | Filing |